Acorn Financial Advisory Services Inc Collegium Pharmaceutical, Inc Transaction History

Acorn Financial Advisory Services Inc

$498 Million
Q2 2025

A detailed history of Acorn Financial Advisory Services Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Acorn Financial Advisory Services Inc holds 37,232 shares of COLL stock, worth $1.28 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

37,232

Previous 38,659 3.69%

Holding current value

$1.28 Million

Previous $1.15 Million 4.6%

% of portfolio

0.22%

Previous 0.25%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	SELL	$24.67 - $30.44 $35,204 - $43,437	-1,427 Reduced 3.69%	37,232 $1.1 Million
Q1 2025 Apr 29, 2025	BUY	$28.04 - $33.91 $279,811 - $338,387	9,979 Added 34.79%	38,659 $1.15 Million
Q4 2024 Feb 14, 2025	SELL	$28.61 - $41.86 $40,883 - $59,817	-1,429 Reduced 4.75%	28,680 $821,000
Q3 2024 Nov 01, 2024	SELL	$31.4 - $39.07 $26,156 - $32,545	-833 Reduced 2.69%	30,109 $1.16 Million
Q2 2024 Aug 01, 2024	SELL	$31.36 - $39.99 $261,479 - $333,436	-8,338 Reduced 21.23%	30,942 $996,000
Q1 2024 May 08, 2024	SELL	$31.23 - $40.91 $237,254 - $310,793	-7,597 Reduced 16.21%	39,280 $1.52 Million
Q4 2023 Jan 17, 2024	SELL	$21.16 - $30.8 $29,137 - $42,411	-1,377 Reduced 2.85%	46,877 $1.44 Million
Q3 2023 Oct 10, 2023	BUY	$21.23 - $24.28 $7,069 - $8,085	333 Added 0.69%	48,254 $1.08 Million
Q2 2023 Jul 20, 2023	SELL	$21.06 - $24.0 $38,455 - $43,824	-1,826 Reduced 3.67%	47,921 $1.03 Million
Q1 2023 Apr 26, 2023	SELL	$23.0 - $29.88 $84,226 - $109,420	-3,662 Reduced 6.86%	49,747 $1.19 Million
Q4 2022 Jan 20, 2023	SELL	$16.14 - $23.55 $58,894 - $85,933	-3,649 Reduced 6.4%	53,409 $0
Q3 2022 Oct 12, 2022	SELL	$15.46 - $20.1 $84,612 - $110,007	-5,473 Reduced 8.75%	57,058 $914,000
Q2 2022 Jul 12, 2022	SELL	$14.22 - $20.88 $32,307 - $47,439	-2,272 Reduced 3.51%	62,531 $1.11 Million
Q1 2022 Apr 18, 2022	SELL	$17.2 - $22.5 $86,584 - $113,265	-5,034 Reduced 7.21%	64,803 $1.32 Million
Q4 2021 Jan 31, 2022	BUY	$17.5 - $21.35 $17,937 - $21,883	1,025 Added 1.49%	69,837 $1.31 Million
Q3 2021 Nov 15, 2021	BUY	$17.75 - $25.39 $214,597 - $306,965	12,090 Added 21.31%	68,812 $1.36 Million
Q2 2021 Jul 23, 2021	BUY	$21.74 - $25.28 $21,587 - $25,103	993 Added 1.78%	56,722 $1.34 Million
Q1 2021 Apr 12, 2021	BUY	$19.25 - $26.1 $40,521 - $54,940	2,105 Added 3.93%	55,729 $1.32 Million
Q4 2020 Jan 25, 2021	BUY	$17.83 - $22.29 $255,521 - $319,437	14,331 Added 36.47%	53,624 $1.07 Million
Q3 2020 Oct 15, 2020	BUY	$15.78 - $20.82 $153,460 - $202,474	9,725 Added 32.89%	39,293 $818,000
Q2 2020 Jul 10, 2020	SELL	$15.49 - $23.51 $743 - $1,128	-48 Reduced 0.16%	29,568 $517,000
Q1 2020 Apr 15, 2020	SELL	$13.89 - $25.45 $24,543 - $44,970	-1,767 Reduced 5.63%	29,616 $484,000
Q4 2019 Jan 27, 2020	BUY	$10.7 - $22.24 $335,798 - $697,957	31,383 New	31,383 $646,000

Others Institutions Holding COLL

# of Institutions

241

Shares Held

36.4M

Call Options Held

52.5K

Put Options Held

200

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.17B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acorn Financial Advisory Services Inc , based on Form 13F filings with the SEC.

News

Stay updated on Acorn Financial Advisory Services Inc with notifications on news.

Account

Acorn Financial Advisory Services Inc Collegium Pharmaceutical, Inc Transaction History